Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Peptidomic characterization and amino acid availability after intake of casein vs. a casein hydrolysate in a pig model

  • Jiménez-Barrios, Pablo
  • Sánchez Rivera, Laura
  • Martínez-Maqueda, D.
  • Le Gouar, Yann
  • Dupont, Didier
  • Miralles, Beatriz
  • Recio, Isidra
This article belongs to the Special Issue Role of Food Digestion and Digestive System in the Nutritional, Functional and Health Properties of Food Bioactives., It is known that casein hydrolysis accelerates gastrointestinal transit in comparison to intact casein, although the effect of the protein hydrolysis on the composition of the digests is not fully understood. The aim of this work is to characterize, at the peptidome level, duodenal digests from pigs, as a model of human digestion, fed with micellar casein and a previously described casein hydrolysate. In addition, in parallel experiments, plasma amino acid levels were quantified. A slower transit of nitrogen to the duodenum was found when the animals received micellar casein. Duodenal digests from casein contained a wider range of peptide sizes and a higher number of peptides above five amino acids long in comparison with the digests from the hydrolysate. The peptide profile was markedly different, and although β-casomorphin-7 precursors were also found in hydrolysate samples, other opioid sequences were more abundant in the casein digests. Within the same substrate, the evolution of the peptide pattern at different time points showed minimal changes, suggesting that the protein degradation rate relies more on the gastrointestinal location than on digestion time. Higher plasma concentrations of methionine, valine, lysine and amino acid metabolites were found in animals fed with the hydrolysate at short times (<200 min). The duodenal peptide profiles were evaluated with discriminant analysis tools specific for peptidomics to identify sequence differences between both substrates that can be used for future human physiological and metabolic studies., This work has received financial support from grants PID2019-107663RB-I00 and PDC2022-133489-I00 funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CCK and GLP-1 response on enteroendocrine cells of semi-dynamic digests of hydrolyzed and intact casein

  • Vivanco-Maroto, Santiaga María
  • Gallo, Verónica
  • Miralles, Beatriz
  • Recio, Isidra
A semi-dynamic gastrointestinal device was employed to explore the link between protein structure and metabolic response upon digestion for two different substrates, a casein hydrolysate and the precursor micellar casein. As expected, casein formed a firm coagulum that remained until the end of the gastric phase while the hydrolysate did not develop any visible aggregate. Each gastric emptying point was subjected to a static intestinal phase where the peptide and amino acid composition changed drastically from that found during the gastric phase. Gastrointestinal digests from the hydrolysate were characterized by a high abundancy of resistant peptides and free amino acids. Although all gastric and intestinal digests from both substrates induced the secretion of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) in STC-1 cells, GLP-1 levels were maximum in response to gastrointestinal digests from the hydrolysate. The enrichment of protein ingredients with gastric-resistant peptides by enzymatic hydrolysis is proposed as strategy to deliver protein stimuli to the distal gastrointestinal tract to control food intake or type 2 diabetes., This work has received financial support from projects PID2019-107663RB-I00 and PDC2022-133489-I00, both, funded by MCIN/AEI/10.13039/501100011033 from the Spanish Ministry of Science and Innovation (MICINN), and the latter counting with funds from EU “NextGeneration EU”/PRTR. SMVM is the recipient of contract (PIE 202070E069) from CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Digestion-released egg peptides induce GLP-1 secretion and modulate postprandial glycemia

  • Vivanco-Maroto, Santiaga María
  • Santos-Hernández, Marta
  • López de las Hazas, María-Carmen
  • Dávalos Herrera, Alberto
  • Herradón, Esperanza
  • Girón, Rocío
  • Paniagua, Nancy
  • López-Miranda, Visitación
  • Miralles, Beatriz
  • Recio, Isidra
Resumen del trabajo presentado a la 8th International Conference on Food Digestion, celebrada en Porto (Portugal) del 9 al 11 de abril de 2024., The intestine is considered the largest endocrine organ in the body due to the variety and the relevance of the hormones secreted at this level. Digestion products from nutrients promote the release of anorexigenic hormones and incretins, such as GLP-1, which is involved in glucose homeostasis regulation. Our previous studies showed that the peptide fraction from egg white digests exerts a potent GLP-1 secretagogue effect in the enteroendocrine cell line STC-1. The screening of different gastrointestinal-resistant peptides in STC-1 cells, showed the sequences from lysozyme (LZ), 109VAWRNRCKGTD119 and 123WIRGCRL129 to be potent GLP-1 and CCK inducers. To determine the key sequence, amino acid deletions and a peptide library based on 123WIRGCRL129 was created. Our results showed a decrease in hormone release for the shorter form 125RGCRL129, and the relevance of 124Ile and the two amino acids at the C-terminal end for cell activation. GLP-1 secretion induced by peptide 123WIRGCRL129 and six alanine-substituted analogs was also assessed in mice jejunal organoids, along with an egg white gastrointestinal digest, and the amino acid Phe, as positive control. GLP-1 response induced by Phe was faster than that exerted by the whole digest or the LZ-derived peptide, but the peptide elicited similar GLP-1 response although it was tested at a 20 times-lower concentration than Phe (peptide at 1 mM vs Phe at 20 mM). Moreover, the results in jejunal organoids confirmed the relevance of the amino acid 124Ile in the LZ-derived peptide, the action of peptidases on 123Trp, and the involvement of ERK- and AMPK-mediated pathways in cell activation and GLP-1 secretion. Oral glucose tolerance tests in Wistar rats after oral administration of 123WIRGCRL129 at 0.1 mM showed a significantly reduction of the blood glucose levels compared to the glucose overload group, while no changes were found in the group receiving the corresponding amino acid mixture at the same concentration. Although more studies are needed to elucidate the mechanism of action of these and other peptides released during digestion, our finding suggest the potential therapeutic application of egg white peptides against type II diabetes., This work has received financial funding from projects PID2019-107663RB-100 and PDC2022-133489-100 (Spanish Ministry of Science and Innovation MICINN/AEI/10.13039/501100011033) and the latter counting with funding from European Union NextGenerationEU/PRTR. SMVM is the recipient of contract (PIE 202070E069) from CSIC. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Milk peptides found in human jejunum induce CCK and GLP-1 secretion and inhibit DPP-IV

  • Gómez-Marín, Cristina
  • Vivanco-Maroto, Santiaga María
  • Miralles, Beatriz
  • Recio, Isidra
Resumen del trabajo presentado a la 8th International Conference on Food Digestion, celebrada en Porto (Portugal) del 9 al 11 de abril de 2024., During food ingestion, gastrointestinal hormones such as glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK) are released in response to nutrients. GLP-1 has a short life due to its degradation by the aminopeptidase dipeptidyl peptidase-IV (DPP-IV), which is expressed at the gastrointestinal tract with maximum secretion in jejunum and ileum, and also circulates in plasma. The role of the DPP-IV enzyme as well as GLP-1, are crucial in glucose homeostasis, especially in type-2 diabetic patients. This work aims to characterize the DPP-IV inhibitory activity and GLP-1/CCK secretagogue effect of peptides derived from the major milk proteins previously found in human jejunal digests after casein or whey oral ingestion. GLP-1 and CCK secretion was evaluated in STC-1 enteroendocrine cells while DPP-IV inhibition was assayed in non-differentiated Caco-2 cells. The intracellular calcium concentration was measured in order to study STC-1 cell activation. Hormone secretion was found to be sequence-specific. For instance, the consecutive loss of amino acids at the N-terminal end of the peptide 6LNVPGEIVE14 reduced stepwise CCK secretion. This same event occurred for peptide 81PVVVPPFLQPE91 where deletion of proline at the N-terminal end reduced both CCK and GLP-1 secretion. However, for peptides 172LPVPQ175 and 59VYPFPGPIPN68 the loss of amino acids at the N-terminal end increased GLP-1 and CCK release. Regarding DPP-IV enzyme inhibition, sequences derived from β-casein 8VPGEIVE14, 85PPFLQPE92, 89QPEV92, 60YPFPG64, and 60YPFPGPI66 were shown to have a strong inhibitory potential on the DPP-IV enzyme, supporting the important role of proline in second Nterminal position for this inhibitory effect. In conclusion, peptide sequences found in human jejunum after ingestion of milk proteins are able to significantly stimulate CCK and GLP-1 secretion, while inhibiting DPP-IV, which is important to reduce hormone degradation. Therefore, these sequences have been shown to have the potential to control postprandial glycemia., This work has received financial funding from projects PID2019-107663RB-100 and PDC2022-133489-100 (Spanish Ministry of Science and Innovation MICINN/AEI/10.13039/501100011033) and the latter counting with funding from European Union NextGenerationEU/PRTR. CGM is the recipient of the contract (PIE 202270E126) from CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A lysozyme-derived peptide induces GLP-1 secretion in mouse jejunal organoids and modulates glycemia in rats

  • Vivanco-Maroto, Santiaga María
  • López de las Hazas, María-Carmen
  • Herradón, Esperanza
  • Girón, Rocío
  • Miralles, Beatriz
  • Paniagua, Nancy
  • López-Miranda, Visitación
  • Dávalos, Alberto
  • Recio, Isidra
Protein digestion products promote the release of incretins, such as GLP-1, which regulate glucose homeostasis. Our previous studies demonstrated that the egg white peptide fraction stimulates GLP-1 secretion in STC-1 cells. Here, the GLP-1 secretion induced by the lysozyme-derived peptide 123WIRGCRL129 and six alanine-substituted analogues was evaluated in mouse jejunal organoids, alongside egg white digest and the amino acid phenylalanine (Phe). Phe induced a faster GLP-1 response, but the peptide 123WIRGCRL129 elicited a similar GLP-1 response, although tested at a 20-fold lower concentration. The GLP-1 release in organoids elicited by the peptide was 57.8 ± 5 pM, while Phe reached 43.7 ± 1 pM at 60 min. In STC-1 cells, the peptide induced 667.7 ± 24.2 pM of GLP-1 compared to 416.6 ± 40.1 pM induced by Phe. Results obtained in STC-1 suggested the involvement of ERK- and AMPK-mediated pathways in the GLP-1 secretion induced by the peptide. Oral glucose tolerance tests in Wistar rats after oral administration of 123WIRGCRL129 showed a reduction in glucose levels, while no changes were observed in the group receiving the amino acid mixture at equimolar concentration. These findings suggest the potential therapeutic application of some food peptides against type 2 diabetes., This work has received financial support from projects PID2023-1465420B-I00 and PDC2022-133489-I00, both funded by MCIN/AEI/10.13039/501100011033 from the Spanish Ministry of Science and Innovation (MICINN), and the latter counting with funds from the EU “NextGeneration EU”/PRTR. S.M.V.-M. is the recipient of a contract (PIE 202070E069) from CSIC. M.-C.L.d.l.H. is a recipient of a Juan de la Cierva Grant (IJC2020-044353-/MCIN/AEI/10.13039/501100011033/EU/PRTR). CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain., Peer reviewed